In this report, the production of Human Growth Hormone increased from 170.67 Million IU in 2012 to 209 Million IU in 2016 with an average growth rate of 5.20%.
Growth hormone (GH), also known as somatotropin (or as human growth hormone in its human form), is a peptide hormone that stimulates growth, cell reproduction, and cell regeneration in humans and other animals. It is thus important in human development. It is a type of mitogen which is specific only to certain kinds of cells. Growth hormone is a 191-amino acid, single-chain polypeptide that is synthesized, stored, and secreted by somatotropic cells within the lateral wings of the anterior pituitary gland.
The downstream industries of Human Growth Hormone products are kids and adults. In the recent years, with the recovery of global economic, the development of emerging countries and the rising health concern, the consumption increase of Human Growth Hormone will be obvious.
For industry structure analysis, the Human Growth Hormone industry is very concentrated. These manufacturers ranging from large multinational corporations to small privately owned companies compete in this industry. The top five producers account for more than 80% of the revenue market. Regionally, North America is the biggest production value area of valves, also the leader in the whole Human Growth Hormone industry.
North America occupied about 42.7% of the production market in 2016. It was followed by Europe and China, which respectively have around 27% and 17% of the global total industry. Other countries have a small amount of production. Geographically, North America was the largest consumption market in the world, which took about 44.6% of the global consumption volume in 2015.
Geographically, this report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of Human Growth Hormone for these regions, from 2014 to 2026 (forecast), covering
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America
Global Human Growth Hormone market competition by top manufacturers/players, with Human Growth Hormone sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
Novo Nordisk
Pfizer
Eli Lilly
Merck Serono
F.Hoffmann-LaRoche
Ferring Pharmaceuticals
GeneScience Pharmaceuticals
Ipsen
LG Life Sciences
Sandoz International
Anhui Anke Biotechnology
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Powder
Solvent
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Human Growth Hormone for each application, including
Growth Hormone Deficiency (GHD)
Turner Syndrome
Chronic Renal Insufficiency
Prader Willi Syndrome
Small for Gestational Age
SHOX Deficiency
Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Summary:
Get latest Market Research Reports on Human Growth Hormone Sales. Industry analysis & Market Report on Human Growth Hormone Sales is a syndicated market report, published as Global Human Growth Hormone Sales Market(Sales,Revenue and competitors Analysis of Major Market)from 2014-2026. It is complete Research Study and Industry Analysis of Human Growth Hormone Sales market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.